Health & Biotech
MGC Pharmaceuticals (ASX: MXC) has changed its name to Argent Biopharma - RGT (ASX: RGT).
Below are the previous articles from MGC Pharmaceuticals (ASX: MXC):
RELATED STOCKHEAD STORIES
Tech
These tech and pharma stocks are looking to M&A to drive growth in global markets
Health & Biotech
MGC Pharma extends working capital runway with $1.25 million raise
Health & Biotech
MGC’s ArtemiC validated by second US$1m order from AMC
Health & Biotech
ASX Health Stocks: AdAlta jumps 40pc after its fibrosis drug shows ‘potential efficacy’ in humans
Health & Biotech
Which ASX health companies are making strides in world’s largest healthcare market?
Health & Biotech
MGC Pharma welcomes Australia’s reclassification of psychedelic compounds
Health & Biotech
Weed Week: A ‘shroom boom’ could see psychedelics follow cannabis’ explosive footsteps
Health & Biotech
First UK patients receive MGC Pharma’s CannEpil product
Health & Biotech
MGC Pharma’s Malta facility is now GMP certified, opening door to markets such as the US
News
ASX Quarterly Wrap: Growing pipeline, milestones, and bullish guidance were the themes for these stocks
Health & Biotech
Could these Aussie psychedelics stocks carve a slice out of a ‘potential $63 billion’ global market?
Health & Biotech
MGC Pharma makes breakthrough after cannabis drug CannEpil made available to UK doctors
News
Closing Bell: When investors say ‘jump!’, the market says ‘how does 1.2% grab ya?’
Health & Biotech
Weed Week: Most Aussies still use illicit cannabis, but more are now turning to prescriptions
Health & Biotech
MGC Pharma granted approval in Slovenia to manufacture and conduct research into the burgeoning space of psychedelics
Experts
MoneyTalks: Two biotechs and a fitness stock that are set to blast off, according to brokers
News